Farms.com Home   Ag Industry News

U.S. corn may be spared from Mexican tariffs

U.S. corn may be spared from Mexican tariffs

Mexico is the number one export destination for American corn

By Diego Flammini
Staff Writer
Farms.com

U.S. corn might not be hit in Mexico’s latest round of retaliatory tariffs.

President Trump announced on May 30 that the United States would impose a 5 percent tariff on all imports from Mexico beginning June 10 unless the country increased its immigration enforcement.

The tariffs could increase to as much as 25 percent by October 1 if Mexico doesn’t meet President Trump’s request.

In response, Mexico is creating a list of U.S. goods to tax.

Mexico’s economy ministry prepared the list and it doesn’t include one key U.S. ag commodity.

“The list submitted to the (Mexican) president’s office excludes U.S. corn,” two sources with knowledge of the situation told Reuters.

But that decision could change, one source said.

Mexico is a substantial market for U.S. corn.

The American ag industry exported more than US$3.3 billion of corn and corn products to Mexico in 2017-2018.

U.S. farmers support the need for immigration control but struggle with being pulled into the political conflict.

“I understand what the president is trying to do,” Angie Williams, a producer from Avon, Ind., told The Guardian Friday. “I support him, I just wish it didn’t affect us so personally.”

Farm groups like the National Corn Growers Association (NCGA) would like to see a different approach to settling this dispute.

The organization “strongly urges the President to rethink applying new tariffs to Mexican goods and to reconsider using tariffs to address non-trade issues,” Lynn Chrisp, president of the NCGA, said in a May 31 statement.

Farms.com has reached out to the U.S. Grains Council and other corn groups for comment on the situation.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.